Samenvatting en analyse van de actuele marktomstandigheden voor life science vastgoed in Nederland.
Despite inventory growth, the Dutch life sciences sector faces facility shortages, driving record rents in science parks. AI integration and ecosystem resilience are key trends for 2025.
Metabolic diseases research, especially obesity, influences real estate strategies. Companies adapt spaces for emerging fields like personalized medicine. Global collaborations with CROs and CDMOs necessitate flexible solutions.
Cost optimization remains crucial amid growing EMEA inventory. The Dutch market is set for transformation in 2025, driven by innovation, strategic partnerships, and focus on prime locations and high-quality assets.